A previous North Carolina blog post discussed a product liability case in which a woman won $417 million against Johnson & Johnson (J&J). The jury found that J&J failed to adequately warn consumers about the cancer risks of asbestos-containing talcum powder. The company now faces another lawsuit, filed on behalf of more than 50 women who also developed ovarian cancer due to J&J talcum powder.
Mesothelioma Awareness Day
Mesothelioma Awareness Day, established by Meso Foundation community members, will take place on September 26 for the 13th year in a row. The campaign is designed to bring awareness and funding to mesothelioma, a disease that claims the lives of thousands each year. The disease has a mortality rate of nearly 64 percent within one year.
Study confirms benefits of trimodal treatment for mesothelioma
A recent study by researchers at the MD Anderson Cancer Center confirms what many North Carolina residents suffering from mesothelioma already know -- mesothelioma patients benefit greatly from undergoing several forms of treatment. The study's researchers found that post-disease diagnosis patients, who undergo multimodal treatment, live almost twice as long as those who do not.
Woman wins $417 million in talc product liability lawsuit
North Carolina residents should know that Johnson & Johnson (J&J) will now have to pay $417 million to a woman who brought a product liability lawsuit. She allegedly developed ovarian cancer from many years of daily application of the company's talcum powder. The jury found that J&J failed to adequately warn consumers about the cancer risks. This was the largest verdict of its kind against J&J, to date.
